URSOSAN 250mg capsule, hard

Similar documents
1. What Ursofalk 250mg hard capsules are and what they are used for

Package leaflet: Information for the user. Ursodeoxycholic Acid Capsules 250mg (Ursodeoxycholic acid)

Package leaflet: Information for the user. Ursodeoxycholic Acid Tablets 150mg (Ursodeoxycholic acid)

Package leaflet: Information for the patient. Destolit 150 mg tablets Ursodeoxycholic acid

Tiorfan Hidrasec Tiorfix Tiorfast 100 mg PACKAGE LEAFLET

BERLITHION 600 mg Capsule, soft

OSPEN 1000; OSPEN ,000,000 IU film-coated tablets; 1,500,000 IU film-coated tablet

SPASMEX FORTE 5mg tablets

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets

Dulcolax 5 mg, film-coated tablets

Consumer Medicine Information TOPICIL. Please read this leaflet carefully before you start using Topicil Capsules.

SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET

FLUIMUKAN PLUS 600 mg effervescent tablets

LIPOFEN SR 250 mg CAPSULE, HARD

SIOFOR mg film-coated tablets

PATIENT INFORMATION LEAFLET SIMVACOR RANGE

PROSCAR 5mg tablets PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT PROSCAR IS AND WHAT IS IT USED FOR

Package leaflet: Information for the patient. Lymelysal 300 mg hard capsules. lymecycline equivalent to 300 mg tetracycline

Irbenida 150 mg film-coated tablets; 300 mg film-coated tablets

Epilepsy is a condition where you have repeated seizures (fits). There are many different types of seizures, ranging from mild to severe.

PANGROL Gastro resistant capsule, hard

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Package leaflet: Information for the patient. Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. Raloxifen STADA 60 mg film-coated tablets (raloxifene hydrochloride)

1. What Solpadol is and what it is used for

Package leaflet: Information for the user. Entecavir Alvogen 0,5 mg filmomhulde tabletten Entecavir Alvogen 1 mg filmomhulde tabletten Entecavir

PACKAGE LEAFLET: INFORMATION FOR THE USER

HERNOVIR 200 mg tablets

Package leaflet: Information for the user

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

SIOFOR mg film-coated tablets

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

Package Leaflet: Information for the User

REDERGIN 1.5 mg tablets; 4.5 mg tablets; 1 mg/ml oral solution

Package leaflet: Information for the patient. Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin

Package leaflet: Information for the user

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets

Irbenida H 150mg/12,5mg film-coated tablets

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

Bonefos 400 mg capsules sodium clodronate

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

PACKAGE LEAFLET: INFORMATION FOR THE USER

FAVISTAN 20 mg, tablets

Package leaflet: Information for the patient. Risedronate sodium 35 mg film-coated tablets. Risedronate sodium

Neuro-Medivitan is a vitamin preparation. Intended use Systemic neurological disorders due to proven deficiency of vitamins B1 and B6.

NEOFEN 60 mg suppository

Package leaflet: Information for the patient. [To be completed nationally] 10 mg film-coated tablets Ebastine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Finasteride 5mg Film-coated Tablets. (Finasteride) This medicine is for use in men only

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride

CONSUMER MEDICINE INFORMATION

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

FASTUM 2.5% gel PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT FASTUM GEL IS AND WHAT IT IS USED FOR

Package leaflet: Information for the user. Finasterid Actavis 5 mg film coated tablets. Finasteride

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. <PRODUCT NAME> 600 mg / 1,000 IU orodispersible tablets. Calcium/cholecalciferol (Vitamin D3)

PATIENT INFORMATION LEAFLET

Atrosan Devil s Claw film-coated tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan

PACKAGE LEAFLET: INFORMATION FOR THE USER

Chemists Own Strong Pain Extra Paracetamol and Codeine Phosphate

Sibelium 5 mg Tablets flunarizine

Read all of this leaflet carefully before you start taking this medicine.

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

Read this entire leaflet carefully before you start taking DYNA BEZAFIBRATE. If you have further questions, please ask your doctor or your pharmacist.

PACKAGE LEAFLET DIASTABOL 50 MG TABLETS. Version 1.0 1

Motens 2 mg and 4 mg Tablets lacidipine

Package leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000

Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution

Package leaflet: Information for the patient

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride)

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol

ELTROXIN thyroxine (as anhydrous levothyroxine sodium) 50 micrograms, 100 micrograms tablets

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. PROSCAR 5 mg Film-coated Tablets (finasteride)

Package leaflet: Information for the patient

LYSOBACT COMPLETE SPRAY ( ) mg / ml Oromucosal spray, solution

Package leaflet: Information for users. Imodium 2 mg orodispersible tablets Loperamide hydrochloride

Package leaflet: Information for the patient. Velphoro 500 mg chewable tablets Iron as sucroferric oxyhydroxide

2. What you need to know before you take fenofibrate

TAFEN NASAL 50mcg nasal spray, suspension

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Package leaflet: Information for the user. CYPROSTAT 50 mg tablet cyproterone acetate

Read all of this leaflet carefully before you start taking this medicine.

PATIENT INFORMATION LEAFLET

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

Package leaflet: Information for the user. Levonorgestrel 1.5 mg Tablet. levonorgestrel

FLUIMUKAN AKUT 600 mg effervescent tablets

Flavamed Forte 30 mg/5 ml, oral solution

Pyrazinamide 500 mg Tablets (Macleods Pharmaceuticals Ltd), TB243. WHOPAR part 3 April 2014 Section 6 updated: May 2014 PACKAGE LEAFLET.

This leaflet answers some common questions about GLUCOBAY tablets. It does not take the place of talking to your doctor or pharmacist.

Transcription:

PACKAGE LEAFLET: INFORMATION FOR THE USER URSOSAN 250mg capsule, hard URSODEOXYCHOLIC ACID This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines the conditions under which the medicine should be used and information on its known safety The product information may be updated several times within its shelf life, and there could be differences between the version of information shown here and other information in the public domain or in the package insert This leaflet may not contain all the information about the medicine or the information may not be the most up to date version for this product If you have any questions or are not sure about anything, ask your doctor or pharmacist Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet You may need to read it again If you have any further questions, ask your doctor or pharmacist This medicine has been prescribed for you only Do not pass it on to others It may harm them, even if their signs of illness are the same as yours If you get any side effects, talk to your doctor or pharmacist This includes any possible side effects not listed in this leaflet What is in this leaflet? 1. What URSOSAN is and what it is used for 2. Before you take URSOSAN 3. How to take URSOSAN 4. Possible side effects 5. How to store URSOSAN 6. Further information 1. WHAT URSOSAN IS AND WHAT IS IT USED FOR URSOSAN contains ursodeoxycholic acid. Ursodeoxycholic acid is a bile acid, which is produced naturally in human bile. URSOSAN may be used For dissolution of gallstones formed from cholesterol. Gallstones should not be seen in X-radiation and should not be greater than 15 mm in diameter. Gallbladder should be functional regardless of the presence of gallstones. For the treatment of inflammation of the stomach wall caused by bile acid reflux (bile reflux gastritis). For the treatment of primary biliary cirrhosis (PBC) (chronic disease of the bile duct that leads to progressive cholestasis and often end-stage liver disease). 2. BEFORE YOU TAKE URSOSAN Do not take URSOSAN if you are hypersensitive to Ursodeoxycholic acid or to any of the other ingredients of the medicine if you have acute inflammation of the gallbladder or biliary tract

if you have biliary tract occlusion (closing the main bile duct or cystic duct) if you suffer from frequent pain like cramps in the upper abdomen (biliary colic) if you have calcified gallstones (which can be seen on X-ray) if you suffer from severe kidney or liver disorder if your gallbladder is not working (not shrinking) properly Please ask your doctor about any of the above conditions. You need to ask your doctor if you had any of these conditions. Warnings and Precautions URSOSAN should be used only under medical supervision. In the first three months of treatment, your doctor should monitor liver function every 4 weeks. After this time, liver function should be monitored every 3 months. If you are taking this medicine to dissolve gallstones, your doctor should evaluate the effect of treatment after 6-10 months by X-ray examination. If you are a woman and you are taking URSOSAN to dissolve gallstones, you should use non-hormonal contraception, because the application of hormonal contraceptives may enhance the formation of gallstones. If you are taking this medicine for the treatment of primary biliary cirrhosis (PBC), in rare cases, the clinical symptoms (eg, itching) at the beginning of treatment may worsen. If this occurs, talk to your doctor in order to reduce the initial dose. Please tell your doctor if you have diarrhea, as this may require dose reduction or discontinuation of treatment. Taking other medicines Tell your doctor or pharmacist if you are taking any other medicines, including any that you get without a prescription from your pharmacy, supermarket or health food shop. There is a possibility for the reduction of the effects of the following medicines when taken simultaneously with the URSOSAN: cholestyramine or colestipol, medicines used to lower high levels of cholesterol in the blood ciprofloxacin, an antibiotic used to treat certain infections, nitrendipine (used to treat high blood pressure), dapsone (an anti-infective) and other medicines which are metabolised in a similar way Increased effect of the following medicines is possible when taken simultaneously with the URSOSAN: cyclosporine, a medicine used to suppress the immune system rosuvastatin (used to treat high cholesterol levels) If you are taking this medicine to dissolve gallstones, please notify your doctor if you are taking medicines to lower cholesterol in the blood (such as clofibrate) or medicines that contain estrogen. These medicines can enhance the formation of gallstones and neutralize the effect of ursodeoxycholic acid in the dissolution of stones. Pregnancy and breastfeeding Talk to your doctor before taking this or any other medicine if you are pregnant. Fertility Animal studies showed no effect of this medicine on fertility. There is no data available to show the impact of this medicine on fertility in humans. Pregnancy

No data available, or there is not enough data, on the use of ursodeoxycholic acid in pregnant women. Animal studies have shown that ursodeoxycholic acid can affect the growth and development of the child. You should not take URSOSAN during pregnancy, unless your doctor considers it necessary. Women of reproductive age Even if you are not pregnant, you should talk to your doctor. Women of reproductive age can be treated only if they use reliable contraceptive measures. Non- hormonal contraceptives or oral contraceptives with low-dose of estrogen are recommended. If you are taking URSOSAN to dissolve gallstones, you should use non-hormonal contraception, because the application of hormonal contraceptives may enhance the formation of gallstones. Before starting treatment, your doctor should make sure you are not pregnant. Breast-feeding There are only a few documented cases of the use of this medicine during breast-feeding. The level of ursodeoxycholic acid in breast milk is very low and probably will not cause adverse reactions in infants. Use in children There is no age limit for the use of URSOSAN. The use of URSOSAN depends on the body weight and medical condition. Driving and using machines Medicine does not affect or its effect is insignificant on the ability to drive and use machines. 3. HOW TO TAKE URSOSAN Always take URSOSAN exactly according to the instructions in this package leaflet. You should check with your doctor or pharmacist if you are not sure. Dosage: Approximately 10 mg of ursodeoxycholic acid per kg of body weight, corresponding to: Up to 60 kg 2 capsules 61-80 kg 3 capsules 81-100 kg 4 capsules over 100 kg 5 capsules Swallow URSOSAN whole with a full glass of water, before bedtime. The time required for the dissolution of gallstones is usually 6-24 months. If after 12 months of treatment there is no reduction of the size of gallstones, treatment should not be continued. Every 6 months, your doctor should check whether the treatment is working. It is necessary to check whether the calcification of stones occurred in the meantime. If this is the case, the treatment should be discontinued. Treatment of bile reflux gastritis Dosage and administration: Take 1 capsule daily, in the evening before bedtime, and swallow it whole with a little liquid. The duration of treatment depends on the course of the disease and it usually lasts 10 to 14 days. The duration of treatment is determined by your doctor depending on the course of the disease. Treatment of primary biliary cirrhosis (chronic inflammatory disease of the bile duct) Dosage: In the first three months of therapy URSOSAN capsules should be taken in divided doses in the morning, noon and evening. After the improvement of liver values daily dose may be taken once daily in the evening. Body weight Number of capsules (kg) first 3 months then morning noon evening evening (1 x daily)

47 62 1 1 1 3 63 78 1 1 2 4 79 93 1 2 2 5 94 109 2 2 2 6 over 110 2 2 3 7 The use of URSOSAN for the treatment of primary biliary cirrhosis is not time limited. Note If you are suffering from primary biliary cirrhosis, at the beginning of treatment the symptoms may worsen (eg. Itching). It happens in rare cases. If this occurs, treatment should be continued with a reduced daily dose of medicine. Each week your doctor will increase the daily dose until you reach the required dose. If you take more URSOSAN than you should Symptoms of an overdose may include diarrhea. If you suffer from diarrhea, make sure you drink enough liquids to replace the fluid and electrolyte balance. In the case of permanent diarrhea, please immediately inform your doctor. If you forget to take URSOSAN If you forget to take a dose, take it as soon as you remember. Do not take a double dose next time, but continue taking the medicine as prescribed by your doctor or as indicated in the package leaflet. Talk to your doctor or pharmacist if you have any additional questions. 4. POSSIBLE SIDE EFFECTS Like all medicines, this medicine can cause side effects, although not everybody gets them. Common side effects (affects less than 1 in 10 patients): soft stool or diarrhea. Very rare side effects (affects less than 1 in 10,000 patients): during the treatment of primary biliary cirrhosis: severe pain on the right side of the upper abdomen, worsening (decompensation) of liver cirrhosis, which partially withdraws after discontinuation of therapy. calcification of gallstones hives (urticaria) If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. Reporting of suspected side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. 5. HOW TO STORE URSOSAN Keep out of the reach and sight of children. This medicine should no longer be used after the expiry date printed on the container and box after EXP. Store below 25 C. Shelf life: 4 years.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION What URSOSAN contains The active ingredient is ursodeoxycholic acid. Each capsule contains 250 mg of ursodeoxycholic acid. The other ingredients are maize starch, pregelatinised maize starch, colloidal anhydrous silica, magnesium stearate, gelatin, titanium dioxide, purified water. What URSOSAN looks like and contents of the pack White, hard, gelatin capsules containing white granules. Pack size: 50 capsules Regime of dispensing The medicine is issued on prescription. Manufacturer PRO.MED.CS Praha a.s., Telčsko 1, 140 00 Prague 4, Czech Republic Manufacturer of the medicinal product: PRO.MED.CS Praha a.s., Telčsko 1, 140 00 Prague 4, Czech Republic